Wacker Biotech is now marketing its technology platform for developing and manufacturing Live Microbial Products (LMPs) under the brand name LIBATEC®.
Today, Wacker Chemie AG announced its initial plans for its “Zukunft gestalten” (Shape the Future) efficiency program.
Wacker Chemie AG closed 2019 in line with its own expectations.
In its financial statements for 2019, Wacker Chemie AG intends to take an impairment of around €750 million on the carrying amount of its production facilities for hyperpure polysilicon.
In Q3 2019, Wacker Chemie AG grew sales year over year and, due to special income, also its EBITDA.